Loading...
Loading...
Pharmaceutical Importer Β· #1 buyer for Tamoxifen Β· $2.4M import value Β· 93 shipments Β· UNITED STATES Β· DGFT Verified
AUROBINDO PHARMA USA., INC, is the #1 importer of Tamoxifen from India with $2.4M in import value and 93 verified shipments. AUROBINDO PHARMA USA., INC, holds a 17.2% market share in Tamoxifen imports based in UNITED STATES. The company sources from 1 verified supplier across 49 formulations shipped to 1 country. Overall, AUROBINDO PHARMA USA., INC, imports 27 pharmaceutical products worth $63.1M across 11 therapeutic categories.

Verified from 93 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| EUGIA PHARMA SPECIALITIES LIMITED | $2.4M | 93 | 100.0% |
AUROBINDO PHARMA USA., INC, sources Tamoxifen from 1 verified Indian supplier based on 93 customs records. The primary supplier is EUGIA PHARMA SPECIALITIES LIMITED accounting for 100.0% of imports.
Buyers ranked immediately above and below #1 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | AUROBINDO PHARMA USA., INC, β | UNITED STATES | $2.5M | 85 | $29.8K |
| 2 | ALIUD PHARMA GMBH | GERMANY | $1.3M | 25 | $50.0K |
| 3 | AUROBINDO PHARMA USA INC β | UNITED STATES | $1.2M | 25 | $47.3K |
AUROBINDO PHARMA USA., INC, ranks #1 among 377 Tamoxifen importers from India. Average shipment value of $29.8K compared to the market average of $23.5K. The closest competitors by value are ALIUD PHARMA GMBH.
Destination countries from 93 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $2.4M | 93 | 100.0% |
AUROBINDO PHARMA USA., INC, imports Tamoxifen to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $2.4M.
| Formulation | Value | Shipments |
|---|---|---|
| TAMOXIFEN TABLET 20MG | $226.6K | 6 |
| TAMOXIFEN TABLET 20MG (TAMOXIFEN CITRATE | $199.1K | 4 |
| TAMOXIFEN TABLET 20MG (TAMOXIFEN CITRATETABLETS USP 20 MG - US (30 S COUNT)) (QTY: 54666 PACKS)NOS | $76.4K | 3 |
| TAMOXIFEN TABLET 20MG (TAMOXIFEN CITRATETABLETS USP 20 MG - US (30 S COUNT)) (QTY: 26832 PACKS) | $73.5K | 2 |
| TAMOXIFEN TABLET 20MG (TAMOXIFEN CITRATETABLETS USP 20 MG - US (30 S COUNT)) (QTY: 55402 PACKS) | $71.4K | 3 |
| TAMOXIFEN TABLET 20MG (TAMOXIFEN CITRATETABLETS USP 20 MG - US (30 S COUNT)) (QTY: 55299 PACKS) | $71.2K | 3 |
| TAMOXIFEN TABLET 20MG (TAMOXIFEN CITRATETABLETS USP 20 MG - US (30 S COUNT)) (QTY: 55032 PACKS) | $70.9K | 3 |
| TAMOXIFEN TABLET 20MG (TAMOXIFEN CITRATETABLETS USP 20 MG - US (30 S COUNT)) (QTY: 75975 PACKS) |
What AUROBINDO PHARMA USA., INC, and other importers must comply with to import Tamoxifen from India
U.S. Food and Drug Administration (FDA)
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10β18 months for ANDA approval
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
India exported $8.9M worth of Tamoxifen through 3,139 shipments from 220 suppliers to 104 countries, serving 377 buyers globally. AUROBINDO PHARMA USA., INC, imports $2.4M of this total, accounting for 17.2% of India's Tamoxifen exports with 93 shipments from UNITED STATES. This is verified from 93 customs shipment records covering 49 distinct formulations.
AUROBINDO PHARMA USA., INC,'s average Tamoxifen order value is $25.7K per consignment, based on 93 shipments totaling $2.4M. AUROBINDO PHARMA USA., INC, is based in UNITED STATES and ranks #1 among all Tamoxifen importers from India by value. The company sources from 1 verified supplier in India.
AUROBINDO PHARMA USA., INC, sources Tamoxifen from 1 verified Indian supplier: EUGIA PHARMA SPECIALITIES LIMITED ($2.4M, 100.0%). This is based on 93 customs records.
AUROBINDO PHARMA USA., INC, ranks #1 among 377 Tamoxifen importers from India with a 17.2% market share. The top 3 importers are AUROBINDO PHARMA USA., INC, ($2.5M), ALIUD PHARMA GMBH ($1.3M), AUROBINDO PHARMA USA INC ($1.2M). AUROBINDO PHARMA USA., INC, processed 93 shipments from UNITED STATES.
AUROBINDO PHARMA USA., INC, also imports these advanced oncology products. Each links to the detailed product page.
AUROBINDO PHARMA USA., INC, imports 27 products worth $63.1M. Beyond Tamoxifen, top products include Amoxicillin, Potassium, Cefuroxime, Lenalidomide, Cefpodoxime. View the complete AUROBINDO PHARMA USA., INC, profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Tamoxifen β including regulatory updates, trade policy changes, and competitive landscape analysis β will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify import regulations and drug registration requirements with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records β the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access order-level details, pricing data, supplier connections, and competitive analysis for AUROBINDO PHARMA USA., INC,'s Tamoxifen imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
AUROBINDO PHARMA USA., INC,
Full Company Profile β
27 products Β· $63.1M total trade Β· 11 categories
| $50.0K |
| 1 |
| TAMOXIFEN TABLET 20MG (TAMOXIFEN CITRATETABLETS USP 20 MG - US (30 S COUNT)) (QTY: 37831 PACKS) | $50.0K | 1 |
| TAMOXIFEN TABLET 20MG (TAMOXIFEN CITRATETABLETS USP 20 MG - US (30 S COUNT)) (QTY : 52937 PACKS) | $50.0K | 1 |
AUROBINDO PHARMA USA., INC, imports 49 distinct Tamoxifen formulations from India. The top formulation is TAMOXIFEN TABLET 20MG with 6 shipments worth $226.6K.
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 104+ countries, 377+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Verified from customs records
Access shipment-level records, supplier contacts, and formulation details for AUROBINDO PHARMA USA., INC,.
Request DemoView Pricing βTrade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Tamoxifen. For current order-level data, contact TransData Nexus.